Company Filing History:
Years Active: 2003-2007
Title: Ruxandra Draghia-Alki: Innovator in Growth Hormone Research
Introduction
Ruxandra Draghia-Alki is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of growth hormone research, particularly in developing innovative therapies to address growth deficiencies in animals. Her work has the potential to enhance agricultural practices and improve animal health.
Latest Patents
Ruxandra holds 2 patents related to her research. Her latest patents include a novel polynucleotide encoding a super-active porcine growth hormone releasing hormone analog. This invention addresses inadequate growth due to deficiencies in growth hormone (GR), growth hormone releasing hormone (GHRH), or genetic diseases. The patent outlines several methods, including:
1. A method of treating growth hormone-related deficiencies associated with the growth hormone pathway.
2. A method for treating growth hormone-related deficiencies associated with genetic disease.
3. A method to improve growth performance in an animal.
4. A method of treating an animal having a growth deficiency disease.
5. A method of increasing the efficiency of an animal used for food.
6. A method to enhance growth in an animal.
Career Highlights
Ruxandra is affiliated with the Baylor College of Medicine, where she conducts her research. Her work is instrumental in advancing the understanding of growth hormone mechanisms and their applications in veterinary medicine.
Collaborations
Ruxandra collaborates with Robert J Schwartz, a fellow researcher, to further explore the implications of her findings in the field of growth hormone therapy.
Conclusion
Ruxandra Draghia-Alki's innovative research and patents contribute significantly to the field of growth hormone therapy, offering promising solutions for growth deficiencies in animals. Her work exemplifies the impact of scientific innovation on agriculture and animal health.